<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02061176</url>
  </required_header>
  <id_info>
    <org_study_id>Holbaek Haemorrhoid Study</org_study_id>
    <nct_id>NCT02061176</nct_id>
  </id_info>
  <brief_title>THD Versus Open Haemorrhoidectomy</brief_title>
  <official_title>Transanal Haemorrhoidal Dearterialization (THD) Versus Open Haemorrhoidectomy for the Treatment of Haemorrhoids. An Open Prospective Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Holbaek Sygehus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Holbaek Sygehus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised study comparing Transanal Haemorrhoidal Dearterialization (THD) and Open
      Haemorrhoidectomy (OH) for the treatment of prolapsing haemorrhoids. The primary aim of the
      study is to evaluate the long-term effect on haemorrhoidal symptoms one year postoperatively.

      Secondary endpoints are postoperative pain, complications, effect on anal continence,
      recovery and return to normal activity, quality of life and health cost analysis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Haemorrhoidal Symptoms</measure>
    <time_frame>1-year and 5-years postoperatively</time_frame>
    <description>Five questions regarding haemorrhoidal symptoms (pain, bleeding, itching, soiling and prolapse) are used to grade the symptom load. Each symptom is graded from 0-4, giving a total score from 0-20.
The symptom score is registered preoperatively, 3 and 12 months and 5 years postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>14 days postoperatively</time_frame>
    <description>Postoperative pain is registered using visual analog scale (VAS), by the hospital staff in the immediate postoperative course during hospital stay and by the patient the first 14 days postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1-year and 5-years postoperatively</time_frame>
    <description>Early and late complications are registered at 3 and 12 months and 5 years follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal continence</measure>
    <time_frame>1-year and 5-years postoperatively</time_frame>
    <description>Effect on anal continence is evaluated by Wexner Anal Incontinence Score and Revised Faecal Incotinence Score (RFIS) preoperatively, 3- and 12 months and 5 years postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1-year and 5-years postoperatively</time_frame>
    <description>QoL is evaluated using Short Health Scale, Short Form(SF)-36 and EQ-5D preoperatively, 1-year and 5-years postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health cost analysis</measure>
    <time_frame>1-year and 5-years postoperatively</time_frame>
    <description>Health cost analysis will be based on an estimate of the cost of the operations, recovery of the patients and effect (need for further procedures or medical care).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Transanal Haemorrhoidal Dearterialization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomised to Transanal Haemorrhoidal Dearterialization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Haemorrhoidectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomised to Open Haemorrhoidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal Haemorrhoidal Dearterialization</intervention_name>
    <arm_group_label>Transanal Haemorrhoidal Dearterialization</arm_group_label>
    <other_name>Hemorrhoidal Artery Ligation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Haemorrhoidectomy</intervention_name>
    <arm_group_label>Open Haemorrhoidectomy</arm_group_label>
    <other_name>Milligan Morgan</other_name>
    <other_name>Haemorrhoidectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding
             resistant to rubber band ligation or sclerotherapy

          -  The patient has a Haemorrhoidal Symptom Score of 4 or more

          -  The patient has an American Society of Anaesthesiologists (ASA) score I-II

          -  The patient's age is 18-85 years at inclusion

          -  The patient has had a colonoscopy, sigmoidoscopy or rigid rectoscopy within 3 months
             before inclusion

        Exclusion Criteria:

          -  The patient has had previous operation for haemorrhoids within the last 2 years

          -  The patient has had previous operation for anal incontinence

          -  The patient has an active anal fistula

          -  The patient has an active anal fissure

          -  The patient has anal incontinence for solid stools
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Olaison, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of Surgery, Holbaek County Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement of Surgery, Holbaek County Hospital.</name>
      <address>
        <city>Holbaek</city>
        <zip>4300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2014</study_first_submitted>
  <study_first_submitted_qc>February 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Holbaek Sygehus</investigator_affiliation>
    <investigator_full_name>Per Olov Gunnar Olaison</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Hemorrhoids</keyword>
  <keyword>Haemorrhoids</keyword>
  <keyword>Transanal Haemorrhoidal Dearterialization</keyword>
  <keyword>Transanal Hemorrhoidal Dearterialisation</keyword>
  <keyword>Open Haemorrhoidectomy</keyword>
  <keyword>Open Hemorrhoidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

